Support our Foundation of Myology project
1722 news items
Update of recommendations on musculoskeletal rehabilitation in neuromuscular diseases
On 29/04/2024
Initially drawn up in 2001, the recommendations for good practice on rehabilitation of the musculoskeletal system in neuromuscular diseases have been updated in a therapeutic…
MFM and MRI of the thighs are the assessment tools most sensitive to changes in BMD
On 26/04/2024
In order to define parameters for monitoring and evaluating Becker muscular dystrophy (BMD) that could be used in clinical trials, a Belgian team conducted a…
A Canadian survey highlights the very varied levels of knowledge of many adult neurologists regarding corticosteroid therapy
On 26/04/2024
Adult neurologists specialising in neuromuscular diseases often prescribe long-term corticosteroids, particularly for autoimmune diseases (myositis, myasthenia gravis, etc.): an online survey of 99 Canadian neurologists…
M&M’s – Muscle Monday Seminar – 29 avril – Pierre Klein (UK)
On 25/04/2024
m6a RNA methylation orchestrates IMP1 regulation of microtubules during human motor neuron differentiation 29 April 2024 – from 12 to 1 pm Pierre Klein, PhD (Postdoctoral…
Brody’s disease: reducing diagnostic delays by identifying mowing in childhood
On 25/04/2024
As Brody’s disease is often diagnosed in adulthood, even though discomfort may have been present since childhood, a Dutch team has reviewed the observations of…
AOC 1001 in DM1: positive data after one year of treatment in the MARINA trial
On 25/04/2024
The MARINA trial is a double-blind, placebo-controlled Phase I/II trial which evaluated AOC 1001 for six months in Steinert’s disease (or DM1). It was followed…
A promising aldose reductase inhibitor in SORD-related neuropathy
On 24/04/2024
Identified in 2020, the SORD gene is involved in a relatively frequent form of axonal CMT (CMT 2) and distal hereditary motor neuropathy (dHMN). It…
Chinese study highlights importance of cognitive impairment in myasthenia gravis
On 24/04/2024
The existence of cognitive disorders in autoimmune myasthenia is still debated. Chinese researchers have investigated this question using a battery of tests: 41 patients with…
MYOLOGY 2024: focus on the institute speakers
On 22/04/2024
The 8th International Congress of Myology will be held in Paris from 22 to 25 April 2024. Here are the eight themes that experts from…
Initial results of the “Adult polyglucosan disease” register
On 19/04/2024
The Columbia University team publishes data collected since 2014 in the Columbia University APBD Registry (CAP ) and filled in by patients with adult polyglucosan…
Vamorolone confirms its efficacy over one year in DMD without limiting growth
On 17/04/2024
In 2022 , the first results of a 6-month double-blind trial of vamorolone (Agamree®) versus placebo or prednisone were published. This synthetic steroid has been…
DMD: Commercial go-ahead for givinostat (Duvyzat™) in the USA
On 15/04/2024
Givinostat, a drug developed by Italfarmaco for Duchenne and Becker muscular dystrophies, is a histone deacetylase (HDAC) inhibitor. On 21 March 2024, it was granted…
A probable founder effect in a hereditary neuropathy with cyclic vomiting
On 11/04/2024
French clinicians and biologists report the observations of three families of North African origin who were diagnosed with deficiency of SMVT, a sodium-dependent multi-vitamin transporter:…
GDF5, a “rejuvenating” treatment for age-related neuromuscular deficiency in mice
On 09/04/2024
A study conducted by the MOOVE* research team headed by France Pietri-Rouxel, in collaboration with several teams from the Institute and Sorbonne University, has just…
Researchers from the institute at the IDMC14 conference to present their work
On 09/04/2024
Researchers and clinicians from the Institute of Myology will be present at the 14th International Myotonic Dystrophy Consortium Meeting (IDMC14) which takes place from 9…
Clinicians and researchers from the Institute at the Journées de neurologie de langue française
On 08/04/2024
The Journées de neurologie de langue française will be held in Paris from 9 to 12 April 2024. The main aim of these days is…
Atamyo Therapeutics obtains authorisation to launch a gene therapy clinical trial in limb-girdle muscular dystrophy linked to SGCG
On 08/04/2024
Following several proofs of concept, Atamyo Therapeutics, a spin-off from Geenethon, has obtained authorisation to start a new gene therapy trial in patients suffering from…
Prenatal diagnosis is sometimes complicated by the results of high-throughput sequencing.
On 08/04/2024
A team from Dijon reports on a complex situation involving a consanguineous couple whose foetus carried adevelopmental anomaly known as cystic hygroma: a whole exome…
An ultra-rare myopathy, but important to recognise because it can be treated
On 05/04/2024
Clinicians in London report the observation of a 27-year-old patient diagnosed with arginine-glycine amidino-transferase (AGAT) deficiency myopathy: the clinical picture combined myopathy and cognitive difficulties…
Failure of the ryanodine receptor causes myocardial senescence and fibrosis in DMD
On 04/04/2024
Researchers in the south of France have studied the determinants of the degeneration and fibrosis observed in cardiomyopathy linked to Duchenne muscular dystrophy (DMD) in…
